Mechanism for laser-induced neovascularization in rat choroid: Accumulation of integrin α chain-positive cells and their ligands

Molecular Vision

Volumn 20, Issue , 2014, Pages 864-871

  Nakajima, Takeshi ^a   Hirata, Masayuki ^b,c   Shearer, Thomas R ^c   Azuma, Mitsuyoshi ^a,b,c  

^a SENJU PHARMACEUTICAL CO LTD   (Japan)

^b Senju Laboratory of Ocular Sciences Senju Pharmaceutical Co Ltd   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; ALPHA5 INTEGRIN; CD51 ANTIGEN; FIBRONECTIN; FLUORESCEIN ISOTHIOCYANATE; LIGAND; MATRIX PROTEIN; VITRONECTIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CELL ADHESION ASSAY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; LASER; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RETINA CELL; RETINA NEOVASCULARIZATION; SCLERA; SUBRETINAL NEOVASCULARIZATION; TISSUE DISTRIBUTION;

ANIMALS; CELL ADHESION; CHOROID; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; INTEGRIN ALPHA5; INTEGRIN ALPHAV; LASERS; LIGANDS; MACROPHAGES; MALE; MICROGLIA; PROTEIN BINDING; PROTEIN SUBUNITS; RATS; RATS, INBRED BN; RETINA; VITRONECTIN;

EID: 84903217757     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Yeoh J, Sims J, Guymer RH. A review of drug options in age-related macular degeneration therapy and potential new agents. Expert Opin Pharmacother 2006; 7:2355-68. [PMID: 17109611].
2. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006; 58:353-63. [PMID: 16845209].
3. Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci USA 1996; 93:9764-9. [PMID: 8790405].
4. Cui J, Maberley D, Samad A, Ma P, Ning A, Matsubara JA, Baciu P. Expression of integrins on human choroidal neovascular membranes. J Ocul Biol Dis Infor 2009; 2:12-9. [PMID: 20072642].
5. Takada Y, Ye X, Simon S. The integrins. Genome Biol 2007; 8:215-[PMID: 17543136].
6. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010; 339:269-80. [PMID: 19693543].
7. Millard M, Odde S, Neamati N. Integrin targeted therapeutics. Theranostics 2011; 1:154-88. [PMID: 21547158].
8. Ffrench-Constant C, Hynes RO. Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 1989; 106:375-88. [PMID: 2591321].
9. Jang YC, Tsou R, Gibran NS, Isik FF. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 2000; 127:696-704. [PMID: 10840366].
10. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007; 5:32-40. [PMID: 17635706].
11. Brooks PCCR, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264:569-71. [PMID: 7512751].
12. Francis SEGK, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, Hynes RO. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002; 22:927-33. [PMID: 12067900].
13. Rüegg C, Alghisi GC. Vascular integrins: therapeutic and imaging targets of tumor angiogenesis. Recent Results Cancer Res 2010; 180:83-101. [PMID: 20033379].
14. Nemeth JA, Nakada MT, Trikha M, Lang Z, Gordon MS, Jayson GC, Corringham R, Prabhakar U, Davis HM, Beckman RA. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest 2007; 25:632-46. [PMID: 18027153].
15. Semkova I, Peters S, Welsandt G, Janicki H, Jordan J, Schraermeyer U. Investigation of laser-induced choroidal neovascularization in the rat. Invest Ophthalmol Vis Sci 2003; 44:5349-54. [PMID: 14638737].
16. Miller H, Miller B, Ishibashi T, Ryan SJ. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci 1990; 31:899-908. [PMID: 1692312].
17. Umeda N, Kachi S, Akiyama H, Zahn G, Vossmeyer D, Stragies R, Campochiaro PA. Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. Mol Pharmacol 2006; 69:1820-8. [PMID: 16527907].
18. Honda S, Nagai T, Negi A. Anti-angiogenic effects of non-peptide integrin alphavbeta3 specific antagonist on laser-induced choroidal neovascularization in mice. Graefes Arch Clin Exp Ophthalmol 2009; 247:515-22. [PMID: 19048271].
19. Bejarano-Escobar R, Blasco M, Duran AC, Martin-Partido G, Francisco-Morcillo J. Chronotopographical distribution patterns of cell death and of lectin-positive macrophages/microglial cells during the visual system ontogeny of the small-spotted catshark Scyliorhinus canicula. J Anat 2013; 223:171-84. [PMID: 23758763].
20. Wagner C, Braunger M, Beer M, Rother K, Hansch GM. Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 1994; 2:51-6. [PMID: 8081997].
21. Wasmuth S, Lueck K, Baehler H, Lommatzsch A, Pauleikhoff D. Increased vitronectin production by complement-stimulated human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2009; 50:5304-9. [PMID: 19407013].
22. Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem 2011; 286:20991-1001. [PMID: 21515678].
23. Liu J, Copland DA, Horie S, Wu WK, Chen M, Xu Y, Paul Morgan B, Mack M, Xu H, Nicholson LB, Dick AD. Myeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in mice. PLoS ONE 2013; 8:e72935-[PMID: 23977372].
24. Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK, Wiedemann P. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 2009; 50:1873-9. [PMID: 19098317].
25. Booij JC, Baas DC, Beisekeeva J, Gorgels TG, Bergen AA. The dynamic nature of Bruch's membrane. Prog Retin Eye Res 2010; 29:1-18. [PMID: 19747980].
26. Fu Y, Ponce ML, Thill M, Yuan P, Wang NS, Csaky KG. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Invest Ophthalmol Vis Sci 2007; 48:5184-90. [PMID: 17962472].
27. Yasukawa T, Hoffmann S, Eichler W, Friedrichs U, Wang YS, Wiedemann P. Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist. Curr Eye Res 2004; 28:359-66. [PMID: 15287373].
28. Kim H, Csaky KG. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats. J Control Release 2010; 142:286-93. [PMID: 19895863].